» Articles » PMID: 39959527

Maternal and Neonatal Efficacy and Safety Outcomes of Myo-Inositol in Women With or at High Risk of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis

References
1.
Kulshrestha V, Balani S, Kachhawa G, Vanamail P, Kumari R, Sharma J . Efficacy of myoinositol in treatment of gestational diabetes mellitus in Asian Indian women: A pilot randomized clinical trial. Eur J Obstet Gynecol Reprod Biol. 2021; 260:42-47. DOI: 10.1016/j.ejogrb.2021.02.017. View

2.
Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

3.
Zhang Y, Wang Z, Liu B, Cai J . Pregnancy outcome of overweight and obese Chinese women with gestational diabetes. J Obstet Gynaecol. 2014; 34(8):662-5. DOI: 10.3109/01443615.2014.920787. View

4.
Laitinen K, Poussa T, Isolauri E . Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial. Br J Nutr. 2008; 101(11):1679-87. DOI: 10.1017/S0007114508111461. View

5.
Lubin V, Shojai R, Darmon P, Cosson E . A pilot study of gestational diabetes mellitus not controlled by diet alone: First-line medical treatment with myoinositol may limit the need for insulin. Diabetes Metab. 2016; 42(3):192-5. DOI: 10.1016/j.diabet.2016.01.005. View